UCB, or UCB S.A., is a global biopharmaceutical company headquartered in Belgium. Founded in 1928, UCB has established itself as a leader in the biopharmaceutical industry, focusing on the development of innovative therapies for neurological and immunological disorders. With a strong presence in Europe and North America, UCB is dedicated to improving the lives of patients through its core products, including treatments for epilepsy, Parkinson's disease, and autoimmune conditions.
The company is renowned for its commitment to research and development, which has led to significant milestones such as the launch of several groundbreaking therapies. UCB's unique approach combines advanced science with patient-centric solutions, positioning it as a key player in the global healthcare market. With a robust pipeline and a focus on unmet medical needs, UCB continues to make notable strides in the biopharmaceutical landscape.
+55 vs industry average
Ucb’s score of 93 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ucb?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Ucb's reported carbon emissions
In 2025, UCB reported total greenhouse gas emissions of approximately 871.6 million kg CO2e, comprising 18.9 million kg CO2e from Scope 1, 129,000 kg CO2e from Scope 2, and 944.7 million kg CO2e from Scope 3 emissions. This represents a significant commitment to reducing their carbon footprint, with targets set to reduce absolute Scope 1 and 2 emissions by 73% by 2030 from a 2019 base year, and Scope 3 emissions by 48% within the same timeframe. UCB aims to achieve net-zero emissions across its value chain by 2045. UCB's emissions reduction initiatives include a commitment to ensure that 80% of its suppliers by emissions will have science-based targets by 2028. The company has also set long-term goals to reduce absolute Scope 1 and 2 emissions by 90% and Scope 3 emissions by 90% by 2045. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect UCB's dedication to sustainable practices in the pharmaceutical sector. UCB's headquarters is located in Belgium, and their climate commitments are part of a broader strategy to enhance environmental sustainability and reduce their overall impact on climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Ucb’s Climate Goals (2030 & 2050)
3 goals2045
48% reduction in scope 3 upstream
UCB also commits to reduce absolute scope 3 GHG emissions by 48% within the same timeframe. Additionally, UCB commits that 80% of its suppli…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 3 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
8 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Ucb’s sustainability data and climate commitments
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project